Updates on the latest news and insights from Esperante and its portfolio.
1 June 2023 Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), today announced...